Sugi Predict

Sugi Predict / Targets / CAMK1D

CAMK1D

Calcium/calmodulin-dependent protein kinase type 1D · Q8IU85 · CAMK1D on Sugi Atlas →

23,471 patent compounds predicted against CAMK1D, 14,029 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL98881 SCHEMBL98881 0.57 3/20
SCHEMBL100736 SCHEMBL100736 0.50 3/20
SCHEMBL171455 SCHEMBL171455 0.50 3/20
SCHEMBL101518 SCHEMBL101518 0.45 3/20
SCHEMBL99210 SCHEMBL99210 0.43 3/20
SCHEMBL101240 SCHEMBL101240 0.41 3/20
Ruxolitinib Ruxolitinib (SCHEMBL99225) 1.00 2/20
Ruxolitinib Ruxolitinib (SCHEMBL101279) 1.00 2/20
Ruxolitinib Ruxolitinib (SCHEMBL171319) 1.00 2/20
Tofacitinib Tofacitinib (SCHEMBL322753) 1.00 2/20
SCHEMBL99245 SCHEMBL99245 0.98 2/20
SCHEMBL99371 SCHEMBL99371 0.98 2/20
SCHEMBL103135 SCHEMBL103135 0.98 2/20
SCHEMBL98692 SCHEMBL98692 0.92 2/20
Ruxolitinib Ruxolitinib (SCHEMBL99771) 0.84 2/20
Ruxolitinib Ruxolitinib (SCHEMBL100078) 0.84 2/20
SCHEMBL101345 SCHEMBL101345 0.82 2/20
SCHEMBL100845 SCHEMBL100845 0.80 2/20
SCHEMBL98773 SCHEMBL98773 0.77 2/20
SCHEMBL100309 SCHEMBL100309 0.77 2/20

Clinical trials — most relevant to CAMK1D by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
COMS for Chronic Ulcers Treatment PHASE4RECRUITING
Short-Term Metformin Use in Young, Healthy Adults: Impacts on Exercise Capacity PHASE4COMPLETED
The Efficacy of Computerized Cognitive Remediation Therapy for Chronic Schizophrenia PHASE4COMPLETED
Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients PHASE3ACTIVE_NOT_RECRUITING
Evaluate Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients PHASE3COMPLETED
The G Protein-Coupled Receptor Kinase Type 2 Inhibitor Paroxetine as Adjunctive Therapy to Improve Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus PHASE3UNKNOWN
The Phosphodiesterase 4 Inhibitor Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients PHASE1/PHASE2WITHDRAWN
Anti-Estrogens - A Potential Treatment for Bipolar Affective Disorder in Women? PHASE2COMPLETED
Calcium Channel Blockade in Primary Aldosteronism PHASE2COMPLETED
Autologous Cytokine Induced Killer Cells (CIK) for Chronic Myeloid Leukemia (CML) Patients on Standard Drug Therapy PHASE2COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Antidepressant Effects on cAMP Specific Phosphodiesterase (PDE4) in Depressed Patients PHASE1COMPLETED
Bioequivalence Study of Tacrolimus in Healthy Volunteers PHASE1COMPLETED
Epithelioid Haemangioendothelioma Observational Study nanRECRUITING
Abnormalities in the Effects of Insulin and Exercise on Glucose- and Lipid Metabolism in Obesity and Type 2 Diabetes nanCOMPLETED
Pompe & Pain - Study to Assess Nociceptive Pain in Adult Patients With Pompe Disease nanUNKNOWN
Assessing Bone Calcium Content in Children With Kidney Disease Treated With Two Different Medicines nanUNKNOWN
Rapamycin as a Means of Interference With Reconsolidation of Posttraumatic Stress Disorder-related Traumatic Memory nanCOMPLETED
NTRK 1,2,3 Rearrangements in Patients With Solid Tumors nanACTIVE_NOT_RECRUITING
Influence of Pulse Electromagnetic Field Therapy on Myocardial Ischemia nanRECRUITING
Calmodulin Gene Mutations in Patients With Ventricular Arrhythmia of Unknown Origin - A Screening Study nanWITHDRAWN
Role of Amino Acids and Genetic Disorder in Pathogenesis of Heart Failure nanUNKNOWN
Evaluation of Vasopressin in the Vessels of Ovarian Neoplasms nanCOMPLETED
Diabetes Risk in London and Its Association with Vitamin D by Ethnic Group (DELVE) nanCOMPLETED
Role of Nitric Oxide in Diabetic Patients With Erectile Dysfunction nanCOMPLETED
Relationship of Gestational Age and Urine Concentration of S100B in Preterm and Term Infants in the First Week of Life nanCOMPLETED
Glycine and Magnesium+Thiamine for the Treatment of Primary Ciliary Dyskinesia nanRECRUITING
Biomarkers of CASH nanACTIVE_NOT_RECRUITING
Immunolocalization of 1,25,Dihydroxyvitamin D3 in Aggressive Periodontitis Patients nanCOMPLETED
Genetic Variants Associated With Adolescent Suicide Attempts nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a CAMK1D binder may also engage these)

ProteinNameSimilarity
Q8BW96 — 1.000 Q8BW96 →
CAMK1 Calcium/calmodulin-dependent protein kinase type 1 0.995 landscape →
Q91YS8 — 0.994 Q91YS8 →
Q9TXJ0 — 0.994 Q9TXJ0 →
Q63450 — 0.994 Q63450 →
Q869W6 — 0.993 Q869W6 →
W0LYS5 — 0.993 W0LYS5 →
A8X6H4 — 0.992 A8X6H4 →
PNCK Calcium/calmodulin-dependent protein kinase type 1B 0.992 landscape →
Q8VDF3 — 0.989 Q8VDF3 →
Q6PFQ0 — 0.988 Q6PFQ0 →
DAPK2 Death-associated protein kinase 2 0.988 landscape →
Q6GLS4 — 0.988 Q6GLS4 →
Q54SJ5 — 0.987 Q54SJ5 →
Q9FMP5 — 0.987 Q9FMP5 →
Q2HJF7 — 0.987 Q2HJF7 →
Q5R4K3 — 0.987 Q5R4K3 →
P13234 — 0.986 P13234 →
P11730 — 0.986 P11730 →
RPS6KA1 Ribosomal protein S6 kinase alpha-1 0.986 landscape →
CAMK2D Calcium/calmodulin-dependent protein kinase type II subunit delta 0.986 landscape →
RPS6KA5 Ribosomal protein S6 kinase alpha-5 0.986 landscape →
Q6DEH3 — 0.986 Q6DEH3 →
Q38869 — 0.986 Q38869 →
Q9QYK9 — 0.986 Q9QYK9 →
Q5F3L1 — 0.985 Q5F3L1 →
P28583 — 0.985 P28583 →
Q3E9C0 — 0.985 Q3E9C0 →
Q6PHZ2 — 0.985 Q6PHZ2 →
Q5ZKI0 — 0.985 Q5ZKI0 →